PubRank

Kamran Nazmi

Author PubWeight™ 46.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2008 1.96
2 Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol 2012 1.66
3 In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides. Int J Antimicrob Agents 2009 1.60
4 Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem 2002 1.37
5 Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J Biol Chem 2004 1.26
6 Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J 2008 1.13
7 Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. J Control Release 2012 1.02
8 Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 2004 1.02
9 Sortase A as a tool for high-yield histatin cyclization. FASEB J 2011 1.01
10 Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane. J Biol Chem 2007 0.99
11 Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug Chem 2006 0.96
12 Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem J 2004 0.93
13 Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int J Antimicrob Agents 2011 0.92
14 Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biol Chem 2009 0.92
15 The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem 2006 0.91
16 The role of salivary histatin and the human cathelicidin LL-37 in wound healing and innate immunity. Biol Chem 2010 0.90
17 Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry. J Virol 2006 0.87
18 A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin. Biol Chem 2008 0.87
19 Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin. Biochim Biophys Acta 2011 0.87
20 Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. Biochimie 2008 0.86
21 Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva. Eur J Oral Sci 2002 0.86
22 Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part. Biol Chem 2005 0.85
23 Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold. FASEB J 2009 0.85
24 Identification of salivary components that induce transition of hyphae to yeast in Candida albicans. FEMS Yeast Res 2009 0.83
25 Solid-phase synthesis of a pentavalent GalNAc-containing glycopeptide (Tn antigen) representing the nephropathy-associated IgA hinge region. Carbohydr Res 2010 0.82
26 Lactoferrin-derived antimicrobial peptide induces a micellar cubic phase in a model membrane system. Biophys J 2011 0.82
27 Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference. Biochem Cell Biol 2006 0.82
28 Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. Peptides 2005 0.82
29 A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin. Peptides 2005 0.82
30 Microbicidal effect of the lactoferrin peptides lactoferricin17-30, lactoferrampin265-284, and lactoferrin chimera on the parasite Entamoeba histolytica. Biometals 2010 0.82
31 Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin. Amino Acids 2012 0.81
32 Involvement of the P2X7 purinergic receptor and c-Jun N-terminal and extracellular signal-regulated kinases in cyclooxygenase-2 and prostaglandin E2 induction by LL-37. J Innate Immun 2012 0.81
33 A heterodimer comprised of two bovine lactoferrin antimicrobial peptides exhibits powerful bactericidal activity against Burkholderia pseudomallei. World J Microbiol Biotechnol 2013 0.81
34 M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone. J Cell Physiol 2015 0.81
35 Novel lactoferrampin antimicrobial peptides derived from human lactoferrin. Biochimie 2008 0.80
36 Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Int J Antimicrob Agents 2010 0.79
37 Structural diversity and mode of action on lipid membranes of three lactoferrin candidacidal peptides. Biochim Biophys Acta 2013 0.79
38 Phytosphingosine kills Candida albicans by disrupting its cell membrane. Biol Chem 2010 0.79
39 Bovine and human lactoferricin peptides: chimeras and new cyclic analogs. Biometals 2014 0.79
40 Stress as a determinant of saliva-mediated adherence and coadherence of oral and nonoral microorganisms. Psychosom Med 2003 0.78
41 Bactericidal effect of lactoferrin and lactoferrin chimera against halophilic Vibrio parahaemolyticus. Biochimie 2008 0.78
42 Influence of specific amino acid side-chains on the antimicrobial activity and structure of bovine lactoferrampin. Biochem Cell Biol 2012 0.78
43 Lactoferrin and lactoferrin chimera inhibit damage caused by enteropathogenic Escherichia coli in HEp-2 cells. Biochimie 2012 0.77
44 C- and N-truncated antimicrobial peptides from LFampin 265 - 284: Biophysical versus microbiology results. J Pharm Bioallied Sci 2011 0.77
45 Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection. Biochem Cell Biol 2012 0.77
46 Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin. Biometals 2014 0.77
47 Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans. Biochem Cell Biol 2012 0.77
48 Covalent RGD modification of the inner pore surface of polycaprolactone scaffolds. J Biomater Sci Polym Ed 2012 0.77
49 Identification of the hydroxyapatite-binding domain of salivary agglutinin. Eur J Oral Sci 2013 0.77
50 Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284. Peptides 2005 0.76
51 Sortase A as a tool to functionalize surfaces. Bioconjug Chem 2013 0.76
52 Membrane-active mechanism of LFchimera against Burkholderia pseudomallei and Burkholderia thailandensis. Biometals 2014 0.75
53 Sphingoid bases inhibit acid-induced demineralization of hydroxyapatite. Caries Res 2014 0.75
54 Vitamin C in plasma and leucocytes in relation to periodontitis. J Clin Periodontol 2012 0.75
55 Tailor made plasmin substrates as potential diagnostic tool to test for mastitis. Vet Res Commun 2014 0.75
56 Phytosphingosine Prevents the Formation of Young Salivary Biofilms in vitro. Caries Res 2017 0.75